The Supreme Court of India issued a show-cause notice to Patanjali Ayurved and its managing director, Acharya Balkrishna, on February 27th, 2024, for violating their promise to stop making misleading claims in their advertisements.
Key points:
- The court also restrained Patanjali from advertising any cure claims for diseases listed in the Drugs and Magic Remedies Act, 1954.
- The court criticized both Patanjali and the government, stating that the company was "taking the entire country for a ride" and the government was "not taking action."
- The Centre was asked to file an affidavit outlining steps taken to prevent companies from misrepresenting medicines in media.
- This action follows a writ petition filed by the Indian Medical Association (IMA) against misleading advertisements by Patanjali and other companies.
- Patanjali had previously promised to stop making false claims in November 2023, but the court noted they continued the practice.